These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6238950)

  • 41. Regulation of activated protein C by factor Xa.
    Jane SM; Hau L; Salem HH
    Blood Coagul Fibrinolysis; 1991 Dec; 2(6):723-9. PubMed ID: 1839223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface.
    Mori T; Takeya H; Nishioka J; Gabazza EC; Suzuki K
    Thromb Haemost; 1996 Jan; 75(1):49-55. PubMed ID: 8713779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombin-induced platelet factor Va formation in patients with a gray platelet syndrome.
    Baruch D; Lindhout T; Dupuy E; Caen JP
    Thromb Haemost; 1987 Aug; 58(2):768-71. PubMed ID: 2445043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of platelets upon factor Xa-catalyzed activation of factor VII in vitro.
    Rao LV; Rapaport SI
    Blood; 1988 Aug; 72(2):396-401. PubMed ID: 3135857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domain.
    Borgel D; Gaussem P; Garbay C; Bachelot-Loza C; Kaabache T; Liu WQ; Brohard-Bohn B; Le Bonniec B; Aiach M; Gandrille S
    Biochem J; 2001 Dec; 360(Pt 2):499-506. PubMed ID: 11716779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The light chain of factor Va contains the activity of factor Va that accelerates protein C activation by thrombin.
    Salem HH; Broze GJ; Miletich JP; Majerus PW
    J Biol Chem; 1983 Jul; 258(14):8531-4. PubMed ID: 6688078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoclonal antibodies to human protein C: effects on the biological activity of activated protein C and the thrombin-catalyzed activation of protein C1.
    Suzuki K; Matsuda Y; Kusumoto H; Nishioka J; Terada M; Yamashita T; Hashimoto S
    J Biochem; 1985 Jan; 97(1):127-38. PubMed ID: 2581938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prothrombinase complex assembly on the platelet surface is mediated through the 74,000-dalton component of factor Va.
    Tracy PB; Mann KG
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2380-4. PubMed ID: 6572981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contribution of platelet-derived factor Va to thrombin generation on immobilized collagen- and fibrinogen-adherent platelets.
    Briedé JJ; Heemskerk JW; van't Veer C; Hemker HC; Lindhout T
    Thromb Haemost; 2001 Mar; 85(3):509-13. PubMed ID: 11307823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of regulation of blood coagulation by activated protein C.
    Suzuki K
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1914-20. PubMed ID: 2941962
    [No Abstract]   [Full Text] [Related]  

  • 53. On the mechanism by which complement proteins C5b-9 increase platelet prothrombinase activity.
    Wiedmer T; Esmon CT; Sims PJ
    J Biol Chem; 1986 Nov; 261(31):14587-92. PubMed ID: 3155419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of thrombomodulin and coagulation Factor Va-light chain on protein C activation in vitro.
    Salem HH; Esmon NL; Esmon CT; Majerus PW
    J Clin Invest; 1984 Apr; 73(4):968-72. PubMed ID: 6323539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inactivation of factor Va by plasmin.
    Omar MN; Mann KG
    J Biol Chem; 1987 Jul; 262(20):9750-5. PubMed ID: 2954962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK; Rao AK; Willis J; Colman RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coagulation factor V: an old star shines again.
    Rosing J; Tans G
    Thromb Haemost; 1997 Jul; 78(1):427-33. PubMed ID: 9198191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.
    Miletich JP; Majerus DW; Majerus PW
    J Clin Invest; 1978 Oct; 62(4):824-31. PubMed ID: 701480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factor V and protein S as cofactors to activated protein C.
    Dahlbäck B
    Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Properties of chemically modified protein S: effect of the conversion of gamma-carboxyglutamic acid to gamma-methyleneglutamic acid on functional properties.
    Walker FJ
    Biochemistry; 1986 Oct; 25(20):6305-11. PubMed ID: 2947625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.